![ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson's Disease | SynapCell ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson's Disease | SynapCell](https://synapcell.com/wp-content/uploads/2022/03/Pr%C3%A9sentation1.png)
ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson's Disease | SynapCell
![AD/PD - Advances in Science & Therapy on X: "Thank you for joining AD/PD™ 2022!🙏 We hope to welcome you to the next edition of AD/PD™ on March 28-April 2, 2023 in AD/PD - Advances in Science & Therapy on X: "Thank you for joining AD/PD™ 2022!🙏 We hope to welcome you to the next edition of AD/PD™ on March 28-April 2, 2023 in](https://pbs.twimg.com/media/FOS7FABWYAgDsFQ.jpg:large)
AD/PD - Advances in Science & Therapy on X: "Thank you for joining AD/PD™ 2022!🙏 We hope to welcome you to the next edition of AD/PD™ on March 28-April 2, 2023 in
![ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson's Disease | SynapCell ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson's Disease | SynapCell](https://synapcell.com/wp-content/uploads/2022/03/Signature-HD-2.png)
ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson's Disease | SynapCell
![El BBRC participa a la 16a International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022) | Barcelona Beta El BBRC participa a la 16a International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022) | Barcelona Beta](https://www.barcelonabeta.org/sites/default/files/styles/noticia_ampliada/public/2022-03/ADPD%20%281%29.jpg?itok=0rwF3kyu)